37 followers 博士タロー (HakaseTaro) @Hakase_Taro MK-2206, oral AKT inhibitor advanced solid tumors. Phase 1 trial, NCT00848718, http://t.co/3RChBD468M 10 Jan 2014 Reply Repost Favourite